Feb 20, 2026
Learn more
Navigating Regulatory Expectations for QA in CGT Manufacturing
The rapidly evolving field of cell and gene therapy (CGT) presents unique scientific and operational challenges, alongside increasingly rigorous regulatory expectations. This webinar provides a structured overview of the current global regulatory landscape, highlighting key guidance from the FDA, EMA, and Health Canada, and outlining how these expectations differ from those applied to traditional pharmaceuticals. […]